Serena Xu

2.9k total citations
14 papers, 1.1k citations indexed

About

Serena Xu is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, Serena Xu has authored 14 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Virology, 9 papers in Immunology and 7 papers in Infectious Diseases. Recurrent topics in Serena Xu's work include HIV Research and Treatment (10 papers), Immune Cell Function and Interaction (7 papers) and HIV/AIDS drug development and treatment (5 papers). Serena Xu is often cited by papers focused on HIV Research and Treatment (10 papers), Immune Cell Function and Interaction (7 papers) and HIV/AIDS drug development and treatment (5 papers). Serena Xu collaborates with scholars based in United States, Netherlands and Canada. Serena Xu's co-authors include Bahige M. Baroudy, Julie Strizki, Jayaram R. Tagat, Susan Zolla‐Pazner, Sherri Burda, Lisa Wojcik, John P. Moore, Shawn E. Kuhmann, Stuart W. McCombie and Gregory R. Reyes and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Virology and Journal of Medicinal Chemistry.

In The Last Decade

Serena Xu

14 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Serena Xu United States 10 818 576 529 325 142 14 1.1k
Patrick Dorr United Kingdom 10 930 1.1× 705 1.2× 337 0.6× 409 1.3× 198 1.4× 17 1.4k
Caroline Smith‐Burchnell United Kingdom 9 947 1.2× 727 1.3× 337 0.6× 348 1.1× 202 1.4× 12 1.4k
Malcolm Macartney United Kingdom 9 663 0.8× 523 0.9× 217 0.4× 284 0.9× 213 1.5× 19 1.1k
Amy M. Princiotto United States 18 878 1.1× 658 1.1× 318 0.6× 479 1.5× 165 1.2× 21 1.3k
Peter Kolchinsky United States 9 1.1k 1.3× 467 0.8× 757 1.4× 509 1.6× 188 1.3× 13 1.5k
Hirotomo Nakata Japan 16 835 1.0× 805 1.4× 242 0.5× 351 1.1× 207 1.5× 29 1.3k
Joséphine Sire France 25 1.1k 1.3× 824 1.4× 460 0.9× 738 2.3× 346 2.4× 49 1.8k
Guillaume Mousseau United States 16 742 0.9× 457 0.8× 194 0.4× 464 1.4× 140 1.0× 22 1.1k
Daniah A. D. Thompson United States 7 687 0.8× 357 0.6× 461 0.9× 299 0.9× 57 0.4× 8 920
Joel E. Wright United States 16 605 0.7× 308 0.5× 403 0.8× 400 1.2× 245 1.7× 32 1.2k

Countries citing papers authored by Serena Xu

Since Specialization
Citations

This map shows the geographic impact of Serena Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serena Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serena Xu more than expected).

Fields of papers citing papers by Serena Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serena Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serena Xu. The network helps show where Serena Xu may publish in the future.

Co-authorship network of co-authors of Serena Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Serena Xu. A scholar is included among the top collaborators of Serena Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serena Xu. Serena Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Luo, Wen, Hoang Hai, Hongwen Zhu, et al.. (2024). Combinatorial macrophage induced innate immunotherapy against Ewing sarcoma: Turning “Two Keys” simultaneously. Journal of Experimental & Clinical Cancer Research. 43(1). 193–193. 6 indexed citations
2.
Shen, Xun, Elizabeth B. Smith, Xi Ai, et al.. (2019). Live Cell Membranome cDNA Screen: A Novel Homogenous Live Cell Binding Assay to Study Membrane Protein-Ligand Interaction. SLAS DISCOVERY. 24(10). 978–986. 1 indexed citations
3.
Siu, Tony, Michael D. Altman, Gretchen A. Baltus, et al.. (2018). Discovery of a Novel cGAMP Competitive Ligand of the Inactive Form of STING. ACS Medicinal Chemistry Letters. 10(1). 92–97. 137 indexed citations
4.
Pechter, David, Serena Xu, Marc M. Kurtz, et al.. (2016). Applying Dataflow Architecture and Visualization Tools to In Vitro Pharmacology Data Automation. SLAS TECHNOLOGY. 21(6). 817–823. 2 indexed citations
5.
Marozsan, Andre J., Shawn E. Kuhmann, Carolina Herrera, et al.. (2005). Generation and properties of a human immunodeficiency virus type 1 isolate resistant to the small molecule CCR5 inhibitor, SCH-417690 (SCH-D). Virology. 338(1). 182–199. 128 indexed citations
6.
Strizki, Julie, Cécile Tremblay, Serena Xu, et al.. (2005). Discovery and Characterization of Vicriviroc (SCH 417690), a CCR5 Antagonist with Potent Activity against Human Immunodeficiency Virus Type 1. Antimicrobial Agents and Chemotherapy. 49(12). 4911–4919. 167 indexed citations
7.
Trkola, Alexandra, Shawn E. Kuhmann, Julie Strizki, et al.. (2002). HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use. Proceedings of the National Academy of Sciences. 99(1). 395–400. 249 indexed citations
8.
Tagat, Jayaram R., Stuart W. McCombie, Ruo W. Steensma, et al.. (2001). Piperazine-Based CCR5 antagonists as HIV-1 inhibitors. I: 2(S)-methyl piperazine as a key pharmacophore element. Bioorganic & Medicinal Chemistry Letters. 11(16). 2143–2146. 47 indexed citations
9.
10.
Zolla‐Pazner, Susan, Serena Xu, Sherri Burda, et al.. (1998). Neutralization of Syncytium‐Inducing Primary Isolates by Sera from Human Immunodeficiency Virus (HIV)–Uninfected Recipients of Candidate HIV Vaccines. The Journal of Infectious Diseases. 178(5). 1502–1506. 13 indexed citations
11.
Cecilia, D., Vineet N. KewalRamani, Barbara Volsky, et al.. (1998). Neutralization Profiles of Primary Human Immunodeficiency Virus Type 1 Isolates in the Context of Coreceptor Usage. Journal of Virology. 72(9). 6988–6996. 195 indexed citations
12.
Zolla‐Pazner, Susan, Michael D. Lubeck, Serena Xu, et al.. (1998). Induction of Neutralizing Antibodies to T-Cell Line-Adapted and Primary Human Immunodeficiency Virus Type 1 Isolates with a Prime-Boost Vaccine Regimen in Chimpanzees. Journal of Virology. 72(2). 1052–1059. 58 indexed citations
13.
Hioe, Catarina E., et al.. (1997). Resting Cell Neutralization Assay for HIV-1 Primary Isolates. Methods. 12(4). 300–305. 2 indexed citations
14.
Zolla‐Pazner, Susan, Carl R. Alving, Robert B. Belshe, et al.. (1997). Neutralization of a Clade B Primary Isolate by Sera from Human Immunodeficiency Virus—Uninfected Recipients of Candidate AIDS Vaccines. The Journal of Infectious Diseases. 175(4). 764–774. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrick Dorr Breakdown of academic impact, for papers by Caroline Smith‐Burchnell Breakdown of academic impact, for papers by Malcolm Macartney Breakdown of academic impact, for papers by Amy M. Princiotto Breakdown of academic impact, for papers by Peter Kolchinsky Breakdown of academic impact, for papers by Hirotomo Nakata Breakdown of academic impact, for papers by Joséphine Sire Breakdown of academic impact, for papers by Guillaume Mousseau Breakdown of academic impact, for papers by Daniah A. D. Thompson Breakdown of academic impact, for papers by Joel E. Wright
Rankless by CCL
2026